Literature DB >> 32812013

Author Correction: Seroprevalence of immunoglobulin M and G antibodies against SARS-CoV-2 in China.

Xin Xu1,2, Jian Sun1,2, Sheng Nie1,2, Huiyuan Li3, Yaozhong Kong4, Min Liang1,2, Jinlin Hou1,2, Xianzhong Huang3, Dongfeng Li5, Tean Ma6, Jiaqing Peng7, Shikui Gao8, Yong Shao9, Hong Zhu2, Johnson Yiu-Nam Lau10, Guangyu Wang11, Chunbao Xie12, Li Jiang12, Ailong Huang13, Zhenglin Yang14, Kang Zhang15,16, Fan Fan Hou17,18,19.   

Abstract

An amendment to this paper has been published and can be accessed via a link at the top of the paper.

Entities:  

Year:  2020        PMID： 32812013      PMCID： PMC7433269          DOI： 10.1038/s41591-020-1058-2

Source DB:  PubMed          Journal:  Nat Med        ISSN： 1078-8956            Impact factor:   53.440


Correction to: Nature Medicine 10.1038/s41591-020-0949-6, published online 5 June 2020. In the version of this article initially published, some of the values cited were incorrect. In the second sentence of the first paragraph of the main body of text, the number of confirmed infections (420 million) was incorrect. The correct value is 4.2 million. In Table 1, the ‘Community resident’ row, the percentages for Male (56.4%), IgG+ (1.4%) and IgM+ (1.6%) were incorrect. The correct values are 47.2%, 0.3% and 0.3% (respectively). Also, in the bottom row of Table 1 (Subtotal), the percentage for Male (48.1%) was incorrect. The correct value is 47.7%. The errors have been corrected in the HTML and PDF versions of the article.
  16 in total

1.  Rapid Generation of In-House Serological Assays Is Comparable to Commercial Kits Critical for Early Response to Pandemics: A Case With SARS-CoV-2.

Authors:  Heidi Auerswald; Chanreaksmey Eng; Sokchea Lay; Saraden In; Sokchea Eng; Hoa Thi My Vo; Charya Sith; Sokleaph Cheng; Gauthier Delvallez; Vann Mich; Ngy Meng; Ly Sovann; Kraing Sidonn; Jessica Vanhomwegen; Tineke Cantaert; Philippe Dussart; Veasna Duong; Erik A Karlsson
Journal:  Front Med (Lausanne)       Date:  2022-05-06

2.  Incorporating false negative tests in epidemiological models for SARS-CoV-2 transmission and reconciling with seroprevalence estimates.

Authors:  Rupam Bhattacharyya; Ritoban Kundu; Ritwik Bhaduri; Debashree Ray; Lauren J Beesley; Maxwell Salvatore; Bhramar Mukherjee
Journal:  Sci Rep       Date:  2021-05-07       Impact factor: 4.379

Review 3.  Viral Replication and Antibody Kinetics in the Recognition of Asymptomatic COVID-19 Patients.

Authors:  Samuel Pecho-Silva; Ana Claudia Navarro-Solsol; Vicky Panduro-Correa; Ali A Rabaan; Jorge L Maguiña; Alfonso J Rodriguez-Morales; Kovy Arteaga-Livias
Journal:  Chemotherapy       Date:  2021-05-07       Impact factor: 2.544

4.  Development of a SERS-based lateral flow immunoassay for rapid and ultra-sensitive detection of anti-SARS-CoV-2 IgM/IgG in clinical samples.

Authors:  Haifeng Liu; Erhei Dai; Rui Xiao; Zihui Zhou; Minli Zhang; Zikun Bai; Ying Shao; Kezong Qi; Jian Tu; Chongwen Wang; Shengqi Wang
Journal:  Sens Actuators B Chem       Date:  2020-11-18       Impact factor: 7.460

Review 5.  Human Monoclonal Antibodies: On the Menu of Targeted Therapeutics Against COVID-19.

Authors:  Junsen Chen; Rui Huang; Yiwen Nie; Xinyue Wen; Ying Wu
Journal:  Virol Sin       Date:  2021-01-04       Impact factor: 4.327

Review 6.  Updates on laboratory investigations in coronavirus disease 2019 (COVID-19).

Authors:  Giuseppe Lippi; Brandon M Henry; Fabian Sanchis-Gomar; Camilla Mattiuzzi
Journal:  Acta Biomed       Date:  2020-09-07

7.  SARS-CoV-2 seroprevalence in oncology healthcare professionals and patients with cancer at a tertiary care centre during the COVID-19 pandemic.

Authors:  Thorsten Fuereder; Anna Sophie Berghoff; Gerwin Heller; Helmuth Haslacher; Thomas Perkmann; Robert Strassl; Julia Maria Berger; Hannah Christina Puhr; Judith Kreminger; Florian Moik; Lorenz Schubert; Angelika Martina Starzer; Ariane Steindl; Stefan Winkler; Matthias Preusser; Selma Tobudic
Journal:  ESMO Open       Date:  2020-09

8.  SARS-CoV-2 infection prevalence on repatriation flights from Wuhan City, China.

Authors:  Hayley A Thompson; Natsuko Imai; Amy Dighe; Kylie E C Ainslie; Marc Baguelin; Sangeeta Bhatia; Samir Bhatt; Adhiratha Boonyasiri; Olivia Boyd; Nicholas F Brazeau; Lorenzo Cattarino; Laura V Cooper; Helen Coupland; Zulma Cucunuba; Gina Cuomo-Dannenburg; Bimandra Djaafara; Ilaria Dorigatti; Sabine van Elsland; Richard FitzJohn; Han Fu; Katy A M Gaythorpe; Will Green; Timothy Hallett; Arran Hamlet; David Haw; Sarah Hayes; Wes Hinsley; Benjamin Jeffrey; Edward Knock; Daniel J Laydon; John Lees; Tara D Mangal; Thomas Mellan; Swapnil Mishra; Andria Mousa; Gemma Nedjati-Gilani; Pierre Nouvellet; Lucy Okell; Kris V Parag; Manon Ragonnet-Cronin; Steven Riley; H Juliette T Unwin; Robert Verity; Michaela Vollmer; Erik Volz; Patrick G T Walker; Caroline Walters; Haowei Wang; Yuanrong Wang; Oliver J Watson; Charles Whittaker; Lilith K Whittles; Peter Winskill; Xiaoyue Xi; Christl A Donnelly; Neil M Ferguson
Journal:  J Travel Med       Date:  2020-12-23       Impact factor: 8.490

9.  Screening for SARS-CoV-2 antibodies among healthcare workers in a university hospital in southern France.

Authors:  Chloé Dimeglio; Fabrice Herin; Marcel Miedougé; Jean-Pierre Cambus; Florence Abravanel; Jean-Michel Mansuy; Jean-Marc Soulat; Jacques Izopet
Journal:  J Infect       Date:  2020-09-30       Impact factor: 6.072

10.  The Interaction of Natural and Vaccine-Induced Immunity with Social Distancing Predicts the Evolution of the COVID-19 Pandemic.

Authors:  Michael F Good; Michael T Hawkes
Journal:  mBio       Date:  2020-10-23       Impact factor: 7.867
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.